Hagerty
Hagerty Reports Third Quarter 2026 Results; Increases 2026 Growth Outlook
Year-to-date 2026 Highlights: Strong underlying operational performance with record increase in Members, Written Premium, and Earned Premium Written…
Source
From PR Newswire
289 releases originally issued via PR Newswire. The issuing organizations are responsible for their content.
PAQ Therapeutics
PAQ Therapeutics to Present First Clinical Data for PT0253, a Selective KRAS G12D Degrader, in Late-Breaking Oral Presentation at the 2026 EORTC-NCI-AACR Symposium
Presentation to highlight the initial safety profile and antitumor activity of PT0253 in advanced solid tumors, including in patients who received…
Waters Corporation
Waters Acquires MOBILion Systems, Bringing Advanced Ion-Mobility Separation to its Mass Spectrometry Portfolio with the Speed and Resolution AI Workflows Require for Proteomics Biomarker Discovery
Adds MOBILion's breakthrough SLIM high-resolution ion mobility technology, which separates molecules by size, shape and charge in milliseconds,…
IDEAYA Biosciences, Inc.
IDEAYA Biosciences Reports Financial Results for the Third Quarter 2026 and Provides a Business Update
Data presented at ESMO 2026 collectively supports the potential of darovasertib to become a foundational new therapy across the treatment journey of…
Pie Medical Imaging (PMI)
LIPSIA-STRATEGY trial demonstrates non-inferiority of CAAS vFFR guided revascularization against pressure wire-based FFR revascularization
LIPSIA-STRATEGY evaluated whether revascularization guided by angiography-based FFR using CAAS vFFR (vessel Fractional Flow Reserve), delivers…
U.S GoldMining Inc.
U.S. GoldMining Appoints John DeLucchi to Its Board of Directors to Support Strategic Growth and Advancement of the Whistler Gold-Copper Project, Alaska
U.S. GoldMining Inc. (NASDAQ: USGO) ("U.S. GoldMining" or the "Company") is pleased to announce that its Board of Directors (the "Board") has…
Differentia Bio
Differentia Bio Advances Human Digital Twins with AI-Driven Disease Modeling and Clinical Validation
From millions of molecular measurements to clinically supported therapeutic predictions, Differentia is building AI-powered disease environments for…
Waters Corporation
Waters Corporation (NYSE: WAT) Reports Third Quarter 2026 Financial Results
Company to Provide Starting 2027 Growth Framework on Earnings Conference Call Third Quarter 2026 Highlights Total reported revenue of $1.767 billion…
bQuest
bQuest Launches Longevity Planning Framework to Give Financial Advisors a Playbook for Navigating Aging and Care
New advisor-led framework pairs a five-pillar Longevity Readiness Assessment with a four-step workflow and bQuest's nationwide network of vetted care…